Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Consulting agrmnt
Appointed director
MetaStat, Inc. (MTST) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/16/2018 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
07/16/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "MetaStat Voluntarily Withdraws Listing on the OTCQB and Files Form 15 to Suspend its Reporting Obligations BOSTON, July 16, 2018 -- MetaStat, Inc. , a precision medicine company developing novel anti-metastatic drugs for the treatment of patients with aggressive cancer, today announced the Company is voluntarily deregistering its common stock under Section 12 of the Securities Exchange Act of 1934, as amended and suspending its reporting obligations under Section 15 of the Exchange Act by filing a Form 15 with the Securities and Exchange Commission on July 16, 2018. “After a thorough review of the benefits and risks associated with being a public company, management and the board of directors felt deregistering as an SEC reporting company is in the best interest of the Company and a..."
05/29/2018 10-K Annual Report for the period ended February 28, 2018
05/29/2018 EFFECT Form EFFECT - Notice of Effectiveness:
05/29/2018 EFFECT Form EFFECT - Notice of Effectiveness:
05/25/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/25/2018 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/11/2018 D Form D - Notice of Exempt Offering of Securities:
04/05/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Senior Note",
"Form of Junior Note",
"Form of Note Warrant",
"Form of Note Purchase Agreement",
"Form of Exchange Agreement"
01/16/2018 10-Q Quarterly Report for the period ended November 30, 2017
01/12/2018 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/02/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/19/2017 CT ORDER Form CT ORDER - Confidential treatment order:
10/16/2017 10-Q Quarterly Report for the period ended August 31, 2017
10/05/2017 POS AM Form POS AM - Post-Effective amendments for registration statement:
08/22/2017 8-K Quarterly results
08/07/2017 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
07/17/2017 10-Q Quarterly Report for the period ended May 31, 2017
07/05/2017 D Form D - Notice of Exempt Offering of Securities
06/27/2017 8-K Form 8-K - Current report
06/19/2017 8-K Form 8-K - Current report
05/31/2017 8-K Form 8-K - Current report
05/30/2017 10-K Annual Report for the period ended February 28, 2017
05/08/2017 8-K Form 8-K - Current report
04/28/2017 8-K Form 8-K - Current report
02/16/2017 8-K Form 8-K - Current report
01/23/2017 8-K Form 8-K - Current report
01/17/2017 10-Q Quarterly Report for the period ended November 30, 2016
01/06/2017 EFFECT Form EFFECT - Notice of Effectiveness
01/05/2017 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
01/03/2017 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
12/14/2016 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933
11/03/2016 8-K Unregistered Sales of Equity Securities, Financial Statements and Exhibits
10/27/2016 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy